Yves Van Laethem

2.9k total citations · 1 hit paper
50 papers, 2.1k citations indexed

About

Yves Van Laethem is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Yves Van Laethem has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 20 papers in Epidemiology and 12 papers in Pharmacology. Recurrent topics in Yves Van Laethem's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Pneumonia and Respiratory Infections (9 papers). Yves Van Laethem is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Pneumonia and Respiratory Infections (9 papers). Yves Van Laethem collaborates with scholars based in Belgium, France and United Kingdom. Yves Van Laethem's co-authors include Paul M. Tulkens, Françoise Van Bambeke, Jean Klášterský, Patrice Courvalin, Y. Glupczynski, Patrick Lebecque, Narcisa Mesaros, Johan Van Eldere, M. Roussel‐Delvallez and Patrick Plésiat and has published in prestigious journals such as Annals of Internal Medicine, Cancer and The American Journal of Medicine.

In The Last Decade

Yves Van Laethem

48 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019

2020 561 citations Jérôme R. Lechien, Carlos M. Chiesa‐Estomba et al. Journal of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yves Van Laethem Belgium	17	675	512	490	346	334	50	2.1k
Hyun‐Ha Chang South Korea	30	924 1.4×	768 1.5×	704 1.4×	319 0.9×	224 0.7×	117	2.4k
Shio‐Shin Jean Taiwan	23	761 1.1×	538 1.1×	858 1.8×	223 0.6×	239 0.7×	45	2.1k
Maddalena Peghin Italy	28	994 1.5×	749 1.5×	622 1.3×	422 1.2×	240 0.7×	89	2.4k
Sun Young Cho South Korea	25	872 1.3×	445 0.9×	337 0.7×	162 0.5×	332 1.0×	145	2.0k
Hideharu Hagiya Japan	21	454 0.7×	460 0.9×	470 1.0×	266 0.8×	246 0.7×	307	2.2k
Christine J. Kubin United States	23	1.4k 2.1×	834 1.6×	789 1.6×	461 1.3×	261 0.8×	53	2.8k
Wentao Ni China	21	709 1.1×	355 0.7×	678 1.4×	268 0.8×	338 1.0×	47	2.0k
Markos Marangos Greece	30	942 1.4×	958 1.9×	675 1.4×	184 0.5×	418 1.3×	180	2.9k
You-ning Liu China	27	565 0.8×	857 1.7×	826 1.7×	142 0.4×	370 1.1×	89	2.4k
Alberto Enrico Maraolo Italy	23	1.1k 1.6×	609 1.2×	407 0.8×	141 0.4×	204 0.6×	83	2.3k

Countries citing papers authored by Yves Van Laethem

Since Specialization

Citations

This map shows the geographic impact of Yves Van Laethem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Van Laethem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Van Laethem more than expected).

Fields of papers citing papers by Yves Van Laethem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Van Laethem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Van Laethem. The network helps show where Yves Van Laethem may publish in the future.

Co-authorship network of co-authors of Yves Van Laethem

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Van Laethem. A scholar is included among the top collaborators of Yves Van Laethem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Van Laethem. Yves Van Laethem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lechien, Jérôme R., Carlos M. Chiesa‐Estomba, Sammy Place, et al.. (2020). Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019. Journal of Internal Medicine. 288(3). 335–344. 561 indexed citations breakdown →

Munter, Paul De, Frédéric Frippiat, Frédérique Jacobs, et al.. (2017). Tekenbeten en de ziekte van Lyme. 46(3). 136–141. 1 indexed citations

Verhaegen, Jan, Johan Flamaing, Wilfried De Backer, et al.. (2014). Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009–2011. Eurosurveillance. 19(31). 14–22. 33 indexed citations

Bambeke, Françoise Van, Joerg Harms, Yves Van Laethem, & Paul M. Tulkens. (2008). Ketolides: pharmacological profile and rational positioning in the treatment of respiratory tract infections. Expert Opinion on Pharmacotherapy. 9(2). 267–283. 29 indexed citations

Quoilin, Sophie, Isabelle Thomas, Christiane Gérard, et al.. (2006). Management of potential human cases of influenza A/H5N1: lessons from Belgium. Weekly releases (1997–2007). 11(4). E060126.1–E060126.1. 2 indexed citations

Laethem, Yves Van, Pierre Van Damme, Nancy Thiry, et al.. (2005). RECOMMENDATIONS FOR THE USE OF THE 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN ADULTS: A BELGIAN CONSENSUS REPORT.. Acta Clinica Belgica. 60(6). 329–337. 7 indexed citations

Bambeke, Françoise Van, Yves Van Laethem, Patrice Courvalin, & Paul M. Tulkens. (2004). Glycopeptide Antibiotics. Drugs. 64(9). 913–936. 164 indexed citations

Snoeck, Robert, et al.. (2001). Treatment of a Bowenoid Papulosis of the Penis With Local Applications of Cidofovir in a Patient With Acquired Immunodeficiency Syndrome. Archives of Internal Medicine. 161(19). 2382–2382. 12 indexed citations

Wit, Stéphane De, S Sprecher, Yves Van Laethem, et al.. (1998). Salvage anti HIV triple therapy with Foscarnet in combination with Nelfinavir and Nevirapine in heavily pretreated patients. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations

10.

Laethem, Yves Van & C. A. Lopes. (1996). Treatment of Onchocerciasis. Drugs. 52(6). 861–869. 18 indexed citations

11.

Camp, Guy Van, et al.. (1995). Adult onset Kawasaki disease diagnosed by the echocardiographic demonstration of coronary aneurysms. European Heart Journal. 16(8). 1155–1157. 9 indexed citations

12.

Lévy, Jack, et al.. (1989). Contaminated Enteral Nutrition Solutions as a Cause of Nosocomial Bloodstream Infection: A Study Using Plasmid Fingerprinting. Journal of Parenteral and Enteral Nutrition. 13(3). 228–234. 77 indexed citations

13.

Lévy, Jack, et al.. (1987). High pressure liquid chromatographic quantitation of teicoplanin in human serum. Journal of Antimicrobial Chemotherapy. 19(4). 533–539. 13 indexed citations

14.

Laethem, Yves Van & Jean Klášterský. (1986). Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin againstKlebsiella pneumoniae andPseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases. 5(1). 110–114. 4 indexed citations

15.

Maubeuge, J. De, Pierre Reding, Christian Tielemans, et al.. (1985). Vasculite cutanée révélatrice d’une hépatite chronique: à propos de 2 cas. Dermatology. 171(5). 349–354. 1 indexed citations

16.

Frühling, J, et al.. (1984). 111Indium-oxine-labeled leukocytes in the diagnosis of localized infection in patients with neoplastic disease. Cancer. 54(5). 817–824. 26 indexed citations

17.

Piccart, M., Jean Klášterský, F. Meunier, et al.. (1984). Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia. Antimicrobial Agents and Chemotherapy. 26(6). 870–875. 86 indexed citations

18.

Laethem, Yves Van, Hjalmar Lagast, M. Husson, & Jean Klášterský. (1983). Serum bactericidal activity of cefoperazone and ceftazidime at increasing dosages against Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 12(5). 475–480. 6 indexed citations

19.

Clumeck, Nathan, et al.. (1982). Cefotaxime Therapy of Serious Infections with Multiresistant Gram-Negative Bacilli. Scandinavian Journal of Infectious Diseases. 14(1). 57–60. 8 indexed citations

20.

Efira, André, et al.. (1980). Lithium in Haematology: A Case of Acute Intoxication. Acta Haematologica. 64(6). 335–337. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact